Related Experiment Videos
[Acute, idiopathic, bilateral uveitis with periphlebitis--case report]
Agnieszka Nowosielska1, Wojciech Czarnecki, Joanna Brydak-Godowska
1Z Oddziału Okulistycznego Wojewódzkiego Szpitala Bródnowskiego w Warszawie.
Klinika Oczna
|August 27, 2005
Summary
A healthy male with bilateral uveitis and periphlephritis unresponsive to standard treatment achieved remission with immunosuppressive therapy. This case highlights novel therapeutic options for severe, idiopathic uveitis.
Area of Science:
- Ophthalmology
- Immunology
Background:
- Idiopathic uveitis and periphlephritis can be challenging to treat.
- Standard anti-inflammatory treatments may fail in severe cases.
Observation:
- A 35-year-old male presented with acute, bilateral uveitis and periphlephritis of unknown origin.
- Initial treatment with acyclovir, ciprofloxacin, and corticosteroids (Encorton) did not resolve the inflammation.
Findings:
- The patient's condition did not improve with conventional anti-inflammatory and steroid therapy.
- Initiation of immunosuppressive therapy with Rapamycin and Endoxan led to the remission of ocular inflammation.
Implications:
- Immunosuppressive therapy can be effective for refractory idiopathic uveitis with periphlephritis.
- This case suggests Rapamycin and Endoxan as potential treatment options for severe, treatment-resistant uveitis.
- Preservation of visual acuity was achieved through this alternative therapeutic approach.